US FDA accepts supplemental New Drug Application and grants Priority Review for Jardiance® for adults with heart failure independent of left ventricular ejection fraction

If approved, Jardiance would be the first clinically proven treatment for adults across the full spectrum of heart failure regardless of ejection fraction RIDGEFIELD, Conn. and INDIANAPOLIS , Nov. 11 , 2021 /PRNewswire/ -- The U.S.   Food and Drug Administration (FDA) has accepted a supplemental